Catalog No. K1076

EdU Imaging Kits (Cy5)

EdU试剂盒(红色荧光),兼容成像或者流式检测
EdU Imaging Kits (Cy5)
规格价格货期数量
1kit(50-500 tests)
¥600.00
¥300.00
现货
仅用于科研,不用于诊疗。未经明确授权不得转售。
B
021-55669583sales@apexbio.cnAPExBIO

特色产品

Annexin V-FITC/PI Apoptosis Kit
Annexin V-FITC/PI Apoptosis Kit
用于双染检测细胞凋亡和坏死
- 在10-20分钟内完成染色
- 适用于流式细胞仪和荧光显微镜检测
- 准确区分活细胞/凋亡细胞/坏死细胞
Phos binding reagent (Phosbind) acrylamide
Phos binding reagent (Phosbind) acrylamide
分离和检测磷酸化/非磷酸化蛋白
- 新型的磷酸盐结合标签和功能分子
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8)
用于细胞增殖和细胞毒性试验
- 比MTT,MTS或WST-1更敏感
- 对细胞无毒性
- 步骤更简单,无需有机溶剂
Cy5 TSA Fluorescence System Kit
Cy5 TSA Fluorescence System Kit
Cy5荧光标记的酪胺信号放大系统
- 检测ICC/IHC/ISH中的低丰度靶点
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
用于观察mRNA运送,定位,翻译
- 具有Cap1结构的荧光素酶mRNA
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
HotStart™ 2X Green qPCR Master Mix
HotStart™ 2X Green qPCR Master Mix
用于荧光定量目标DNA或cDNA
- 通过热启动机制优化扩增特异性
- 优异的扩增效率、可重复性和稳定性
- 卓越的灵敏度和准确性,操作简单
HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus
HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus
高效的Cy5修饰RNA转录试剂盒
- 适合原位/Northernblot杂交实验
- 优化的缓冲液和T7 RNA聚合酶混合物
- 20 μL反应体系可获得更高的RNA产量

产品描述

测量细胞增殖和细胞周期是评估细胞健康、确定遗传毒性和评估药物药效的基本方法,常用的方法是直接测量DNA 的合成。在以往的实验中常用方法包括掺入放射性核苷(3H-thymidine)或BrdU等。而EdU Cell Proliferation Kits (Cy5)则采用了一种新的方法:点击化学-CuAAC(铜催化的叠氮化物-炔烃环加成反应),使用该反应可直接测量在细胞周期S期的DNA合成。

在基于BrdU的检测中,需要额外的DNA变性(通常使用HCl、加热或用DNase消化)以使BrdU暴露于抗BrdU抗体。胸腺嘧啶核苷类似物EdU(5-ethynyl-2’-deoxyuridine)是BrdU的理想替代品,因为它不受苛刻的DNA变性条件的影响,EdU可以在DNA合成过程中掺入DNA链中。EdU的炔基是一种生物惰性基团,可以通过CuAAC反应与染料的叠氮基发生极强的选择性反应,从而生成1, 2, 3-三唑产物。EdU和Cy5 Azide具有生物学上独特的基团,其连接后可以荧光标记增殖细胞的DNA,具有低背景和高检测灵敏度。这种CuAAC反应可在极温和的条件下提供出色的区域选择性和定量转化。该反应是高效的,并且可以通过流式细胞术或荧光显微镜定量地使用。

EdU Cell Proliferation Kits (Cy5) 采用的是Cy5 Azide与EdU进行连接后荧光标记增殖细胞的DNA,本试剂盒经过优化,可以通过荧光显微镜或者流式细胞仪进行检测。按说明书操作,对于96孔板成像,本试剂盒可以使用100次;对于6孔板成像,本试剂盒可以使用50次。如果需要使用流式细胞仪检测,本试剂盒可以使用25次。

产品特点

操作简单,所需时间更少,无需变性步骤或苛刻的处理

效率高,亮度高

更好的保护细胞形态,抗原结构和DNA完整性

由于不使用可变的BrdU抗体,因此具有很高的一致性

产品性质

产品有效期12个月
运输条件蓝冰
注意事项本产品仅限于科研使用,不得用于临床诊断或治疗。

产品组分

组分组分货号组分规格保存条件
Hoechst 33342 (10 mg/mL in Water) (Component G)A3472S135uL-20°C避光
Cy5 Azide (Component B)A8128P11vial-20°C避光
EdU Buffer Additive (Component F)B2064400mg-20°C
EdU (Component A)B83375mg-20°C
DMSO (Component C)S03624mL室温
10X EdU Reaction Buffer (Component D)S03664mL-20°C
CuSO4 (100 mM Aqueous Solution) (Component E)S03671vial-20°C
运输条件:蓝冰
产品有效期:12个月

操作说明

常见问题

1)Q:不同货号的EdU可以检测多少个样品?

A:EdU Imaging Kits(货号K1075与K1076)如果用于培养的细胞(6孔板)的检测,可以检测50个样品,每个样品的反应体系为500 μL的cocktail反应液;如果用于12孔、24孔、48孔,96孔,384孔板样品的检测,分别可以检测125、250、350、500、1250个样品,每个样品推荐的反应液用量为200 μL、100 μL、70 μL、50 μL、20 μL;
EdU Imaging Kits(货号K1075与K1076)如果用于冰冻或石蜡切片的检测,可以检测125-250个样品,每个样品的反应体系为100-200 μL的cocktail反应液。EdU Flow Cytometry Assay Kits(货号K1077与K1078)如果用于流式细胞仪检测,可以检测100个样品,每个细胞样品的细胞数量宜为10-100万,每个样品的反应体系为500 μL的cocktail反应液。

2)Q:EdU可否用于动物体内注射?

A:EdU可以通过注射或进食等方式进行动物的体内标记。如以小鼠为例,可以按照10-200 mg/kg的用量,用PBS配制成一定浓度的EdU,腹腔注射、特定组织或器官局部注射或者加入饮用水中,4小时后或根据特定实验确定的适当时间后,快速处死小鼠,取出所需的组织,按照常规步骤制作冰冻切片或石蜡切片。具体用量跟所用动物的种类、体重和使用方式有关。

3)Q:能否在活细胞中进行Click EdU检测?

A:不可以。Click反应体系中的叠氮化物检测试剂和缓冲液组分是细胞非透过型,检测EdU信号时的Click反应必须在固定和通透的样品上进行。

4)Q:Cy3与Cy5有什么区别?

A:荧光基团不同,检测时发射荧光的颜色不同(Cy3 azide最大激发波长555 nm, 最大发射波长570 nm;Cy5 azide最大激发波长646 nm,最大激发波长662 nm),两者的实验效果相同,可根据个人需求进行选择。

5)Q:样本检测不到EdU阳性信号?

A:可能原因及解决方案如下:

a) 所用试剂可能变质,不要使用已经变黄的添加剂或缓冲液;

b) 确保样本发生增殖,可设置阳性对照以确认染色过程无误;

c) EdU处理时间太短,细胞实验一般EdU处理时间宜为细胞周期长度的1/5-1/10,阳性率约为20%-30%,动物实验一般根据目的组织细胞的增殖速度进行时间调整,若细胞增殖速度慢,可延长EdU处理时间;

d) 染色过程干片、固定和通透不充分等因素,实验操作要严谨。

6)Q:样本背景信号很强应该怎么处理?

A:可能原因包括:染色后洗涤不充分,可增加洗涤次数;染色过程中干片导致染料粘附严重;多聚甲醛固定时间过长;没有阳性信号而曝光过度导致背景严重等等,同时可以设置对照组(无染料或无Click反应)排除自发荧光干扰。

APExBIO 顾客使用本产品发表的 32 篇科研文献

1. Zhijuan Wang, Jinzhen Huang, et al. "Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway." PLoS One. 2026 Jun 12;21(6):e0350584. PMID: 42284354

2. Xiaodong Deng, Faqi Zhu, et al. "A Pumilio-dependent post-transcriptional mechanism drives pulmonary hypertension via KCNK3 suppression." Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Volume 1872, Issue 6, August 2026, 168243. PMID: 41946195

3. Liu Yi, Wenming He, et al. "ALDOB K87 lactylation drives mitochondrial fission and metabolic reprogramming in pulmonary hypertension." Commun Biol. 2026 Mar 27. PMID: 41896623

4. Dandan Wang, Mei Li, et al. "Mitocytosis, mitophagy, and apoptosis coordinately drive mitochondrial clearance to regulate myogenic differentiation." J Adv Res. 2026 Jan 26:S2090-1232(26)00090-1. PMID: 41605286

5. Yi Liu, Xiaodong Deng, et al. "NDRG1–HIF1α interaction in hypoxic signaling for pulmonary hypertension." International Journal of Biological Macromolecules Volume 339, Part 1, January 2026, 149857. PMID: 41456779

6. Ling Zhu, Qimei Tan, et al. "Artemisitene triggers calcium-dependent ferroptosis by disrupting the LSH-EWSR1 interaction in colorectal cancer." Redox Biol. 2026 Feb;89:103950. PMID: 41337810

7. James Bartram, Sydney Treichel, et al. "Activation of a branched-chain amino acid rheostat restores replication-dependent hematopoietic stem cell fitness." Cell Stem Cell Volume 33, Issue 2p289-305.e6February 05, 2026

8. Wangcheng Xie, Tingyi Luo, et al. "From stem cells to nanomedicine: A multimodal approach targeting pancreatic fibrosis via MFGE8-dependent ANXA1-SMAD2/3 axis." International Journal of Biological Macromolecules Volume 338, Part 1, January 2026, 149698

9. Jiayong Luo, Jinyu Chang, et al. "NDRG2 Drives DRP1 Phosphorylation to Promote the Progression of Pulmonary Hypertension." Front. Biosci. (Landmark Ed) 2026; 31(4): 48054

10. Yingjuan Wu, Yi Liu, et al. "HIF1α/PRDX1 axis drives pulmonary vascular remodeling through DRP1 DeSUMOylation and mitochondrial fragmentation." Biochim Biophys Acta Mol Basis Dis. 2025 Nov 3:168094. PMID: 41192649

11. Yuanna Jiang, Fang Peng, Yibo Chen. "UHRF1-mediated HIF-1α stabilization promotes ovarian cancer through metabolic reprogramming and angiogenesis." Cell Death Dis. 2025 Oct 24;16(1):751. PMID: 41136379

12. Xiaodong Deng, Yixuan Liu, Yingzhao Liang. "The HIF1α-PUM1-KCNK3 axis drives pulmonary hypertension by destabilizing KCNK3 mRNA in pulmonary artery smooth muscle cells." Biochim Biophys Acta Mol Basis Dis. 2025 Oct 22:168092. PMID: 41135634

13. Yang Zhou, Xueying Wang, et al. "A positive feedback loop between SERPINH1 and MMP-9/TGF-β1 promotes lung adenocarcinoma progression." Cell Death Differ. 2025 Aug 16. PMID: 40819105

14. Chuang Zhao, Xin-nan Zheng, et al. "Modeling tumor relapse using proliferation tracing and ablation transgenic mouse." NPJ Breast Cancer. 2025 Jul 17;11(1):73. PMID: 40675988

15. Yongliang Liu, Hui Hua, et al. "Mechanism by which the molecular glue - like verteporfin induces IRE1α dimerization and activation to synergize with AKT inhibition in breast cancer." Cell Chem Biol. 2025 Jun 19;32(6):854-871.e6. PMID: 40472846

16. Lina Shan, Xiaofeng Tang, et al. "Targeting BMPER as a therapeutic strategy for pulmonary arterial hypertension." Cell Signal. 2025 Sep:133:111880. PMID: 40383173

17. Jiaojiao Wang, et al. "Pan-cancer analysis identifies tRNA modification enzyme CTU2 as a novel tumor biomarker and its role in immune microenvironment." Front Immunol. 2025 May 1:16:1547794. PMID: 40375999

18. Qiqi Gao, Mengjia Zhang, et al. "Microsecond pulsed electric fields induce myocardial ablation by secondary mitochondrial damage and cell death mechanisms." Scientific Reports.15, Article number: 10132 (2025) PMID: 40128377

19. Xiaodong Deng, Qing Que, et al. "Mechanistic insights into the role of EGLN3 in pulmonary vascular remodeling and endothelial dysfunction." Respir Res. 2025 Feb 21;26(1):61. PMID: 39985019

20. Yan Liao, Junkai Chen, et al. "Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma." J Transl Med. 2025 Jan 22;23(1):103. PMID: 39844299

21. Xiaodong Deng, Yong You, et al. "MMP8-mediated vascular remodeling in pulmonary hypertension." Biochim Biophys Acta Mol Basis Dis. 2025 Feb;1871(2):167582. PMID: 39581558

22. Meng Wang, Yupeng Wang, et al. "nNOS-Mediated S-Nitrosylation of TCOF1 Regulates KRAS Proteostasis to Suppress Hepatoblastoma Progression." Redox Biology Available online 20 September 2025, 103870

23. Jingwen Xu, Yue Li, et al. "Impaired mitochondrial degradation of CHCHD2 promotes metabolic dysfunction - associated steatohepatitis - related hepatocellular carcinoma by upregulating VEGFA." Oncogene 44, 1475–1487 (2025)

24. Fu-Gang Xiao, Zhou Yang, Shi-Yan Yu. "N7-methylguanosine-related gene decapping scavenger enzymes as a novel biomarker regulating epithelial cell function in diabetic foot ulcers." World J Diabetes. Nov 15, 2025; 16(11): 109455

25. Baosen Shan, Yangan Huo, et al. "miR-184, a downregulated ovary-elevated miRNA transcriptionally activated by SREBF2, exerts anti-apoptotic properties in ovarian granulosa cells through inducing SMAD3 expression." SMAD3 expression. Cell Death Dis 15, 892 (2024) PMID: 39695116

26. Zhennan Guo, Qiang Zeng, et al. "LncRNA NORFA promotes the synthesis of estradiol and inhibits the apoptosis of sow ovarian granulosa cells through SF-1/CYP11A1 axis." Biol Direct 19, 107 (2024) PMID: 39523350

27. Wentao Zuo, Haoyang Ma, et al. "Phosphorylation of RelA/p65 Ser536 inhibits the progression and metastasis of hepatocellular carcinoma by mediating cytoplasmic retention of NF-κB p65." Gastroenterol Rep (Oxf). 2024 Nov 4:12:goae094. PMID: 39498383

28. Chunlei Zhang, Huan Yang, et al. "Genome-Wide Analysis Reveals Copy Number Variant Gene TGFBR3 Regulates Pig Back Fat Deposition." Animals (Basel). 2024 Sep 12;14(18):2657. PMID: 39335247

29. Yi Liu, Changqing He, et al. "Tadalafil Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells-Derived Exosomes in Pulmonary Hypertension by Upregulating miR-29a-3p." International Journal of Nanomedicine Volume 19, 2024 - Issue

30. Zhaojie Wang, Yuxin Bai, et al. "Two-Way Regulation of MgFe-LDH on ESC Cell Fate via Temporal Selective Activation of Different Cell Membrane Receptors." ADVANCED FUNCTIONAL MATERIALS Volume34, Issue33 August 14, 2024 2314112

31. Huan Yang, Chunlei Zhang, et al. "A Functional Single Nucleotide Polymorphism in the 3' Untranslated Region of the Porcine JARID2 Gene Is Associated with Aggressive Behavior of Weaned Pigs after Mixing." Int J Mol Sci. 2023 Dec 19;25(1):27. PMID: 38203196

32. Ronghua Huang, Bingbiao Lin, et al. "Prenatal Exposure to General Anesthesia Drug Esketamine Impaired Neurobehavior in Offspring." Cell Mol Neurobiol. 2023 Aug;43(6):3005-3022. PMID: 37119312

摩尔浓度计算器

质量
= 浓度
x 体积
x 分子量
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Apexbio的产品页面获得)批次特异的分子量使用本工具。
产品目录
产品目录
质量认证
产品目录
联系我们
通讯
获取最新资讯,产品折扣和优惠。
Copyright ©2013-2026 APExBIO Technology. All Rights Reserved.沪公网安备 31011002003500沪公网安备 31011002003500沪ICP备14019579号-3